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ticle under the CC BY-NC-ND license (Septic cavernous sinus thrombosis (SCST) is a rare and se-
vere complication following odontogenic infection.1 The
irregularly shaped cavernous sinus is a collection of thin
wall veins comprising trabeculae that are highly prone to
bacterial infection and emboli formation. The facial veins
and pterygoid plexus receive blood from this region. In-
fections of the orbits, middle face, nose, tonsil, soft pal-
ate, and jaws can spread to the cavernous sinus by this
route.2 The sequelae of SCST often result in impaired
eyeball movement, vision loss, and death.3 A 47-year-old
woman presented with a painful swelling in her left middle
face for 4 days. On clinical examination, left side peri-
orbital swelling and ptosis, impaired vision acuity, con-
junctiva edema, and limited eyeball movement were
identified (Figures 1A and 1B). Computed tomography
revealed fluid-like material accumulation in the left
maxillary sinus, with destruction of the medial wall and
orbital floor. In addition, extraocular muscle compression
and displacement were observed. Irregular enhancement
was identified along the left lateral side of the sella turcica
(Figures 1C and 1D). The orthopantogram revealed a peri-
odontally compromised tooth of #26. Serology tests showed
an elevated white blood cell count (11,870/mL) and C-
reactive protein level (12.09 mg/dL). Furthermore, pyrexia
(39.1C) and tachycardia (109 beats/min) were observed,
indicating impending sepsis progress. After emergent orbit
decompression, functional endoscopic sinus surgery, and0.002
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to receive antibiotic coverage (Teicoplanin, 400 mg,
Piperacillin/Tazobactam, 4 g/0.5 g) and steroid treatment
(Solumedrol, 250 mg, q6h for 3 days, tapered to prednis-
olone 60 mg, qd). The swelling largely subsided on Day 5
after the surgery; however, vision improved only minimally.
In the 4th month of follow-up, entropion, absence of light
perception and pupil light reflex, and minimal oph-
thalmoplegia were observed in the left eye (Figures 1E and
1F). In the past, septic dural sinus thrombosis was poten-
tially lethal; however, antibiotics now offer a cure.1
Certain vital structures, such as cranial nerves III, IV, VI,
V1, and V2 and the internal carotid artery, pass through the
cavernous sinus. The anatomical proximity of these struc-
tures explains the severe neurologic sequelae following
SCST.2 SCST treatments incorporate antibiotics, debride-
ment, steroid, and anticoagulant therapy.4 Antibiotic
coverage should be implemented immediately once a
diagnosis is established. Vancomycin combined with a third
to fourth generation cephalosporin is recommended. Sur-
gery is crucial for infection source removal. However,
debridement of the cavernous sinus is infrequently
executed because of unwarranted complications.5 Steroids
are used because of the antiinflammatory effect that is
considered beneficial for the recovery of neurological
deficits.3 In this case, emergent antibiotics institution
combined with interdisciplinary debridement prevented
further sepsis progressing. We administered high-dose ste-
roids and did not use anticoagulants on the insistence of
the patient. Nevertheless, the left eye healed with some
morbidity. Blindness, mydriasis, and mild ophthalmoplegia
indicated damage of cranial nerves II, III, and IV, respec-
tively. We presumed that severe swelling and compression
of the extraocular muscles compromised the surrounding
blood supply to the optic nerve. Awareness of these unfa-
miliar sequelae of maxillofacial infection should be
emphasized.lic of China. Published by Elsevier Taiwan LLC. This is an open access
ses/by-nc-nd/4.0/).
Figure 1 Clinical and radiographic photographs of the patient. (A) Severe swelling of the left face and ptosis of the left eye. (B)
Chemosis of the left conjunctiva and cornea. (C) Coronal view of contrast-enhanced computed tomography. The left maxillary sinus
is filled with fluid-like material, and the ethmoid sinus is affected. The arrow indicates extraocular muscle swelling and
displacement. (D) Axial view of irregular enhancement and bulging along the left lateral side of the sella turcica (as indicated by
the arrow). (E) At the 4-month follow-up, the swelling has subsided with little orbit decompression scarring. The black arrow
indicates entropion. (F) Mild ophthalmoplegia is observed, particularly on upward gaze. The dotted line indicates mydriasis and no
light perception in the left eye.
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